Resistance in hospitals: Implications for empiric choice of therapy

International Journal of Clinical Practice, Supplement

Volumn , Issue 95, 1998, Pages 9-13

  Masterton, Robert ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CANDIDA ALBICANS; CANDIDA KRUSEI; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; CROSS RESISTANCE; DRUG CHOICE; DRUG CONTROL; DRUG USE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HISTORY OF MEDICINE; HOSPITAL; HOSPITAL COST; HUMAN; LENGTH OF STAY; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; ARTICLE; DRUG UTILIZATION;

DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HOSPITALS; HUMANS;

EID: 0031595646     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Tenover FC, Hughes JM. The challenges of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens. JAMA 1996; 275: 300-304.
2. Hølby N. Epidemiologic aspects on antibiotic resistance. Microbial Drug Resistance 1995; 2: 137-142.
3. Aguiar JM, Chacon J, Canton R et al. The emergence of highly fluroquinolone-resistant Escherichia coli in community-acquired urinary tract infection. J Antimicrob Chemother 1992; 29: 349-350.
4. Goldstein FW, Acar JF and the Alexander Project Collaborative Group Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996; 38(Suppl A): 71-84.
5. Wingard JR. Merz WG, Rinaldo MG et al. Increase in Candida krusei infection in bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-1277.
6. Starr JM, Rogers TR, lmpallomeni M. Hospital-acquired Clostridium difficile diarrhoea and herd immunity. Lancet 1997; 349: 426-429.
7. Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 1996; 17: 236-248.
8. Kitzis MD, Goldstein FW, Acar JF, Selection of one step resistant mutants of S. pneumoniae by levofloxacin compared with other fluoroquinolones. 35th ICAAC 1995; Abstract C126.
9. Chow JW, Fine MJ, Shlaes DM et al. Enterobacter bacteremia; clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-590.
10. Manion FA, Meyer L, Jenne J et al. Loss of antimicrobial susceptibility in aerobic Gram-negative bacilli repeatedly isolated from patients in intensive care units. Infect Control Hosp Epidemiol 1996; 17: 222-226.
11. Leigh DA, Joy GE, Tait S et al. Treatment of acute uncomplicated urinary tract infection with single daily doses of cefuroxime axetil. J Antimicrob Chemother 1989; 23: 267-273.
12. Gross PA, Barrett TL, Dellinger EP et al. Quality standard for the treatment of bacteremia. Infect Control Hosp Epidemiol 1994; 15: 189-192.
13. Jamulitrat S, Meknavin U, Thongpiyapoom S. Factors affecting mortality outcome and risk of developing nosocomial bloodstream infection. Infect Control Hosp Epidemiol 1994; 15: 163-170.
14. Mosdell DM, Morris DM, Voltura A et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214: 546-554.
15. Klem C, Dasta JF. Efforts of pharmacy to reduce antibiotic resistance. New Horizons 1996; 4: 377-384.
16. McGowan JE. Do intensive hospital antibiotic control programmes prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994; 15: 478-483
17. McGowan JE, Gerding DN. Does antibiotic restriction prevent resistance? New Horizons 1996; 4: 370-376.
18. Neu HC. Infection problems for the 1990s - do we have an answer? Scand J Infect Dis 1993; Suppl 91: 7-13.
19. Couper MR. Strategies for the rational use of antimicrobials. Clin Infect Dis 1997; 24(Suppl 1): S154-156.